Incunabula
Bluelighter
- Joined
- Dec 10, 2010
- Messages
- 1,861
I might be wrong, but as I understand it, Baclofen (and phenibut) doesn't cause a "dopamine rebound effect" as GHB does.
With GHB, dopamine release is caused by stimulation of the GHB receptor. Baclofen (and phenibut) doesn't have any affinity for that site, only for GABA-b.
About GHB:
"Activation of both the GHB receptor and GABA(B) is responsible for the addictive profile of GHB. GHB's effect on dopamine release is biphasic.[68] Low concentrations stimulate dopamine release via the GHB receptor.[69] Higher concentrations inhibit dopamine release via GABA(B) receptors as do other GABA(B) agonists such as baclofen and phenibut.[70] After an initial phase of inhibition, dopamine release is then increased via the GHB receptor."
from wiki
And about baclofen:
"Baclofen produces its effects by activating the GABAB receptor, similar to the drug GHB which also activates this receptor and shares some of its effects. However, baclofen does not have significant affinity for the GHB receptor, and has no known abuse potential.[12] The modulation of the GABAB receptor is what produces baclofen's range of therapeutic properties."
With GHB, dopamine release is caused by stimulation of the GHB receptor. Baclofen (and phenibut) doesn't have any affinity for that site, only for GABA-b.
About GHB:
"Activation of both the GHB receptor and GABA(B) is responsible for the addictive profile of GHB. GHB's effect on dopamine release is biphasic.[68] Low concentrations stimulate dopamine release via the GHB receptor.[69] Higher concentrations inhibit dopamine release via GABA(B) receptors as do other GABA(B) agonists such as baclofen and phenibut.[70] After an initial phase of inhibition, dopamine release is then increased via the GHB receptor."
from wiki
And about baclofen:
"Baclofen produces its effects by activating the GABAB receptor, similar to the drug GHB which also activates this receptor and shares some of its effects. However, baclofen does not have significant affinity for the GHB receptor, and has no known abuse potential.[12] The modulation of the GABAB receptor is what produces baclofen's range of therapeutic properties."